An incendiary, deeply reported exposé of Johnson & Johnson, one of America's oldest and most trusted pharmaceutical companies--from an award-winning investigative journalist One day in 2004, Gardiner Harris, early for a flight, sat down at an airport bar and started talking to the woman on the barstool beside him. She was a drug sales rep for Johnson & Johnson, and her horrific story about unethical sales practices and the devastating impact they'd had on her family fundamentally changed the nature of how Harris covered the company--and the entire pharmaceutical industry--for The New York Times. His subsequent investigations and ongoing research since that very first conversation led to new federal laws and ultimately to this book, a blistering exposé of a trusted American institution and the largest healthcare conglomerate in the world. Harris takes us light years away from the company's image as the child-friendly baby company as he uncovers reams of evidence showing decades of deceitful and dangerous corporate practices that have threatened the lives of millions. He covers multiple disasters: lies and cover-ups regarding baby powder's linkage to cancer, the surprising dangers of Tylenol, a criminal campaign to sell antipsychotics in ways that have cost countless lives, a popular drug used to support cancer patients that actually increases the risk that cancer tumors will grow, and deceptive marketing efforts that accelerated opioid addictions through their product Duragesic (fentanyl) that rival even those of the Sacklers and Purdue Pharma. Filled with shocking, infuriating, but utterly necessary revelations, No More Tears is a landmark work of investigative journalism that lays bare the deeply rooted corruption behind the image of babies bathing with a smile. \nAn incendiary, deeply reported exposé of Johnson & Johnson, one of America's oldest and most trusted pharmaceutical companies--from an award-winning investigative journalist One day in 2004, Gardiner Harris, early for a flight, sat down at an airport bar and started talking to the woman on the barstool beside him. She was a drug sales rep for Johnson & Johnson, and her horrific story about unethical sales practices and the devastating impact they'd had on her family fundamentally changed the nature of how Harris covered the company--and the entire pharmaceutical industry--for The New York Times. His subsequent investigations and ongoing research since that very first conversation led to new f